Skip to main content
. 2021 Jan 5;3(2):fcaa233. doi: 10.1093/braincomms/fcaa233

Table 4.

Summary of the diagnostic testing results in patients with autoimmune CNS disorders and alternative diagnosis

Diagnostic test Autoimmune CNS disorder (n = 39) Alternative diagnosis (n = 105) Total (n = 144) P value
Median TPO titre IU/ml (range)a 312.7 259.4 271.5 0.44
(14.4–950) (9.9–950) (9.9–950)
(N = 22) (N = 75) (N = 97)
Low vitamin B12 6/26 (23.1) 1/70 (1.4) 7 (7.3) 0.001
Non-neural antibodies 6/34 (17.6) 17/90 (18.9) 23/124 (18.5) >0.99
Neural antibodies in serum 14/39 (35.9) 21/101 (20.8) 35/140 (25) 0.08
MRI abnormalities suggesting AE 8 (20.5) 4/104 (3.8) 12/143 (8.4) 0.003
Abnormal EEG 14/33 (42.4) 14/85 (16.5) 28/118 (23.7) 0.007
Abnormal PET 8/14 (57.1) 18/42 (42.9) 26/56 (46.4) 0.37
CSF inflammatoryb 20/39 (51.3) 20/88 (22.7) 40/127 (31.5) 0.002
 WBCs, >5 cells/μl 9/39 (23.1) 1/88 (1.1)c 10/127 (7.9) <0.001
 Protein level, >50 mg/dl 16/39 (41) 20/88(22.7) 36/127 (28.3) 0.05
 Positive OCB 4/30 (13.3) 0/81 (0) 4/111 (3.6) 0.005
 Elevated IgG index and synthesis rate 3/29 (10.3) 0/81(0) 3/110 (2.8) 0.017

Categorical data is provided as number (percentage). Bold values denote statistically significant results (P < 0.05).

TPO, thyoperoxidase antibody; WBC, white blood cells; OCB, oligoclonal bands.

a

Patients with abnormal (>9) value at Mayo Clinic.

b

CSF inflammatory: WBC, >5 cells/μl, positive OCBs, high IgG index or synthesis rate.

c

This patient had adult-onset neuronal intra-nuclear inclusion disease.